SG11201405829WA - Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections - Google Patents
Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infectionsInfo
- Publication number
- SG11201405829WA SG11201405829WA SG11201405829WA SG11201405829WA SG11201405829WA SG 11201405829W A SG11201405829W A SG 11201405829WA SG 11201405829W A SG11201405829W A SG 11201405829WA SG 11201405829W A SG11201405829W A SG 11201405829WA SG 11201405829W A SG11201405829W A SG 11201405829WA
- Authority
- SG
- Singapore
- Prior art keywords
- cocktails
- compositions
- treatment
- bacterial infections
- phages
- Prior art date
Links
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B2017/320004—Surgical cutting instruments abrasive
- A61B2017/320008—Scrapers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Surgery (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261612531P | 2012-03-19 | 2012-03-19 | |
PCT/PT2013/000016 WO2013141730A1 (en) | 2012-03-19 | 2013-03-19 | Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201405829WA true SG11201405829WA (en) | 2014-10-30 |
Family
ID=48534472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201405829WA SG11201405829WA (en) | 2012-03-19 | 2013-03-19 | Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections |
Country Status (14)
Country | Link |
---|---|
US (1) | US9962419B2 (en) |
EP (1) | EP2833899B1 (en) |
JP (1) | JP6186427B2 (en) |
CN (1) | CN104519893B (en) |
AU (1) | AU2013235883B2 (en) |
BR (1) | BR112014023321B1 (en) |
CA (1) | CA2867418C (en) |
DK (1) | DK2833899T3 (en) |
ES (1) | ES2814024T3 (en) |
HK (1) | HK1207002A1 (en) |
PT (1) | PT2833899T (en) |
RU (1) | RU2654596C2 (en) |
SG (1) | SG11201405829WA (en) |
WO (1) | WO2013141730A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2865383A1 (en) * | 2013-10-25 | 2015-04-29 | Pherecydes Pharma | Phage therapy of pseudomonas infections |
WO2016066722A2 (en) * | 2014-10-28 | 2016-05-06 | Ian Humphery-Smith | Bacteriophage combinations for human or animal therapy |
US10455983B2 (en) | 2015-09-10 | 2019-10-29 | Prince Castle LLC | Modular food holding system |
US20170157186A1 (en) * | 2015-12-02 | 2017-06-08 | Smart Phage, Inc. | Phage to treat bacteria on skin |
WO2017180862A1 (en) * | 2016-04-13 | 2017-10-19 | Northeast Ohio Medical University | Gpnmb compositions for treatment of skin wounds |
CA3045284A1 (en) * | 2016-12-05 | 2018-06-14 | Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa | Bacteriophage compositions comprising respiratory antibacterial phages and methods of use thereof |
EP3679579A1 (en) * | 2017-09-05 | 2020-07-15 | Adaptive Phage Therapeutics, Inc. | Methods to determine the sensitivity profile of a bacterial strain to a therapeutic composition |
WO2019079710A1 (en) * | 2017-10-19 | 2019-04-25 | Buice Mona E | Topical composition for improved healing of open wounds |
WO2019118310A1 (en) * | 2017-12-11 | 2019-06-20 | Adaptive Phage Therapeutics, Inc. | Phage dispensing system |
EP3735275A1 (en) | 2018-01-02 | 2020-11-11 | Armata Pharmaceuticals, Inc. | Therapeutics bacteriophage compositions for treating staphylococcus infection |
CN109082414B (en) * | 2018-06-29 | 2020-11-13 | 浙江工业大学 | Staphylococcus aureus bacteriophage and application thereof |
CA3107463A1 (en) | 2018-07-24 | 2020-01-30 | Medimmune, Llc | Antibody directed against s. aureus clumping factor a (clfa) |
CN109730235A (en) * | 2019-02-01 | 2019-05-10 | 珠海横琴普罗恩能医用食品有限公司 | A kind of preservative for medical food |
US20220233615A1 (en) * | 2019-05-21 | 2022-07-28 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Bacteriophages for the treatment of tuberculosis |
CN111643724B (en) * | 2020-07-01 | 2022-01-28 | 南京大学 | Preparation method and application of hydrogel wound dressing loaded with bacteriophage and acidic fibroblast growth factor |
WO2022013318A1 (en) | 2020-07-14 | 2022-01-20 | Biontech R&D (Austria) Gmbh | New mosaic bacteriophages and uses thereof |
WO2022013314A1 (en) | 2020-07-14 | 2022-01-20 | Biontech R&D (Austria) Gmbh | Bacteriophage cocktails and uses thereof |
CN112251439B (en) * | 2020-10-26 | 2022-06-21 | 齐鲁师范学院 | Arabidopsis thaliana high-temperature induction promoter pHTG1 and recombinant vector thereof |
CN112301001B (en) * | 2020-11-03 | 2022-10-14 | 华中农业大学 | Staphylococcus aureus phage LSA2311 and application thereof |
CN113201458B (en) * | 2020-12-21 | 2022-05-27 | 青岛诺安百特生物技术有限公司 | Composition for improving stability of phage preparation and application thereof |
AU2022272135A1 (en) * | 2021-05-12 | 2024-01-04 | Biomx Ltd. | Staphylococcus bacteriophage and uses thereof |
DE202022102100U1 (en) | 2022-04-20 | 2022-04-27 | Prabhakar Ramesh Bhandari | Synergistic antibiotic pharmaceutical composition for treatment of Staphylococcus aureus infections |
WO2024115430A1 (en) * | 2022-11-28 | 2024-06-06 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Acinetobacter baumannii phages |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995027043A1 (en) | 1994-04-05 | 1995-10-12 | Exponential Biotherapies, Inc. | Antibacterial therapy with genotypically modified bacteriophage |
US5863560A (en) | 1996-09-11 | 1999-01-26 | Virotex Corporation | Compositions and methods for topical application of therapeutic agents |
US6138401A (en) | 1999-06-25 | 2000-10-31 | Duncan; Franklin R. | Fish hook remover |
JP2005520545A (en) * | 2002-03-25 | 2005-07-14 | ザ ユニバーシティ オブ ワーウィック | Antibacterial agent |
US20050095222A1 (en) | 2003-10-29 | 2005-05-05 | Taro Suzuki | Allergen inhibitor, allergen-inhibiting method, allergen-inhibiting fiber and allergen-inhibiting sheet |
MX2007005279A (en) | 2004-11-02 | 2008-03-11 | Gangagen Life Sciences Inc | Bacteriophage compositions. |
AU2005301046B2 (en) | 2004-11-02 | 2012-02-23 | Chr. Hansen A/S | Stabilized bacteriophage formulations |
CA2593992A1 (en) | 2004-12-06 | 2006-06-15 | Rodney M. Donlan | Inhibition of biofilm formation using bacteriophage |
AU2006251827B2 (en) | 2005-05-26 | 2012-05-31 | Chr. Hansen A/S | Bacterial management in animal holding systems |
BRPI1008663B8 (en) | 2009-02-06 | 2021-10-05 | Technophage Investig E Desenvolvimento Em Biotecnologia S A | bacteriophage with a genome, pharmaceutical composition, use of a therapeutically effective amount of the pharmaceutical composition, method of diagnosing the causative agent of a bacterial infection, and use of the bacteriophage |
PT104837A (en) | 2009-11-24 | 2011-05-24 | Technophage Investiga O E Desenvolvimento Em Biotecnologia S A | PACKAGES OF FACTS ENTEROC? CICOS AND M? ALL FOR ITS USE |
SG188566A1 (en) | 2010-09-17 | 2013-04-30 | Tecnifar Ind Tecnica Farmaceutica S A | Antibacterial phage, phage peptides and methods of use thereof |
-
2013
- 2013-03-19 EP EP13725496.7A patent/EP2833899B1/en active Active
- 2013-03-19 RU RU2014141941A patent/RU2654596C2/en active
- 2013-03-19 BR BR112014023321-7A patent/BR112014023321B1/en active IP Right Grant
- 2013-03-19 US US14/385,828 patent/US9962419B2/en active Active
- 2013-03-19 WO PCT/PT2013/000016 patent/WO2013141730A1/en active Application Filing
- 2013-03-19 CA CA2867418A patent/CA2867418C/en active Active
- 2013-03-19 PT PT137254967T patent/PT2833899T/en unknown
- 2013-03-19 ES ES13725496T patent/ES2814024T3/en active Active
- 2013-03-19 SG SG11201405829WA patent/SG11201405829WA/en unknown
- 2013-03-19 DK DK13725496.7T patent/DK2833899T3/en active
- 2013-03-19 JP JP2015501614A patent/JP6186427B2/en active Active
- 2013-03-19 CN CN201380022586.5A patent/CN104519893B/en active Active
- 2013-03-19 AU AU2013235883A patent/AU2013235883B2/en active Active
-
2015
- 2015-08-11 HK HK15107764.2A patent/HK1207002A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112014023321B1 (en) | 2022-06-14 |
RU2654596C2 (en) | 2018-05-21 |
CN104519893A (en) | 2015-04-15 |
AU2013235883A1 (en) | 2014-10-02 |
AU2013235883B2 (en) | 2018-01-04 |
HK1207002A1 (en) | 2016-01-22 |
PT2833899T (en) | 2020-09-15 |
DK2833899T3 (en) | 2020-09-28 |
CA2867418A1 (en) | 2013-09-26 |
EP2833899B1 (en) | 2020-06-24 |
EP2833899A1 (en) | 2015-02-11 |
CA2867418C (en) | 2020-03-10 |
US20150150919A1 (en) | 2015-06-04 |
ES2814024T3 (en) | 2021-03-25 |
JP6186427B2 (en) | 2017-08-23 |
JP2015512384A (en) | 2015-04-27 |
CN104519893B (en) | 2020-02-07 |
RU2014141941A (en) | 2016-05-20 |
WO2013141730A1 (en) | 2013-09-26 |
US9962419B2 (en) | 2018-05-08 |
BR112014023321A2 (en) | 2022-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1207002A1 (en) | Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections | |
HK1222398A1 (en) | Compositions and methods for the treatment of burkholderia infections | |
PL2627334T3 (en) | Compositions for use in the treatment of viral infections | |
HK1205696A1 (en) | Compositions for topical treatment of microbial infections | |
HK1210018A1 (en) | Tailored liposomes for the treatment of bacterial infections | |
EP2761029A4 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
PL2696890T3 (en) | Treatment of microbial infections | |
EP2655603A4 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
GB201217097D0 (en) | Treatment of bacterial infection | |
HRP20160150T1 (en) | Treatment of streptococcal infections | |
AP2015008338A0 (en) | Compounds for the treatment and prevention of retroviral infections | |
HK1202539A1 (en) | (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel (r)-(r)(s)- | |
IL233486A (en) | Synthetic peptides for treatment of bacterial infections | |
HK1207981A1 (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions | |
ZA201503474B (en) | Compositions and methods for treating bacterial infections | |
EP2969003A4 (en) | Methods and compositions for bacteria infections | |
EP2844258A4 (en) | Methods and compositions for treating bacterial infection | |
EP2916653A4 (en) | Antibiotic methods and compositions for bacteria infections | |
EP2906216A4 (en) | Inhibitors of dna gyrase for the treatment of bacterial infections | |
HK1175786A1 (en) | Synthetic lta mimetics and use thereof as vaccine component for therapy and/or prophylaxis against gram-positive infections lta / | |
PT2862576T (en) | Microorganisms and compositions comprising them for use in the treatment or prevention of mastitis | |
EP2529728A4 (en) | Pharmaceutical compositions for the treatment of bacterial infections | |
EP2772248A4 (en) | Pharmaceutical composition and kit for treating bacterial infections | |
EP2665738A4 (en) | Compounds for use in the treatment of bacterial infection | |
EP2670407A4 (en) | Treatment of bacterial infections |